FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

3727211000001109: Chloroquine phosphate 250mg tablets 20 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22072501000001117 Chloroquine phosphate 250mg tablets 20 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22072601000001118 Chloroquine phosphate 250mg tablets 20 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Chloroquine phosphate 250mg tablets 20 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Chloroquine phosphate 250mg tablets 20 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Chloroquine phosphate 250mg tablets 20 tablet Is pack of Product containing precisely chloroquine phosphate 250 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Chloroquine phosphate 250mg tablets 20 tablet Has active ingredient Chloroquine phosphate false Inferred relationship Existential restriction modifier
Chloroquine phosphate 250mg tablets 20 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Chloroquine phosphate 250mg tablets 20 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Chloroquine phosphate 250mg tablets 20 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Chloroquine phosphate 250mg tablets 20 tablet Has VMP Product containing precisely chloroquine phosphate 250 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Chloroquine phosphate 250mg tablets 20 tablet Has specific active ingredient Chloroquine phosphate true Inferred relationship Existential restriction modifier
Chloroquine phosphate 250mg tablets 20 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Avloclor 250mg tablets (AstraZeneca) 20 tablet 2 x 10 tablets Is a True Chloroquine phosphate 250mg tablets 20 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start